UHC's 2027 Part D formulary guide: Xarelto stays on Tier 3, plus new drugs, tier moves, and non-formulary drugs with alternatives across MAPD, C-SNP, and PDP formularies.
75 Medicare product pages on the Broker Link, each with product support, provider and drug lookups, plan documents, and enrollment material ordering.
The 2027 Part D story is bigger than a national average. With the Premium Stabilization Demonstration ending after 2026, agents could see greater variation in standalone PDP premiums from plan to plan. Learn what changed, why the spread matters more
Never miss an episode. Follow us on your favorite podcast app.
Subscribe to the weekly eNewsletter. Stay informed on what is changing, what is coming
next, and what your agency needs to know to keep growing.
